Items Tagged ‘farydak’

April 22nd, 2015

Panobinostat

By

Class: Biological Therapy Generic Name: Panobinostat Trade Name: Farydak® For which conditions is this drug approved? Farydak® is approved for use, in combination with Velcade® (bortezomib) and dexamethasone, in people with multiple myeloma after they’ve had at least two other types of treatment. What is the mechanism of action? Farydak is an agent known as a […]

View full entry

Tags: Biological Therapy, Drug Dictionary, farydak, Multiple Myeloma, P, panobinostat


April 22nd, 2015

Farydak®

By

Class: Biological Therapy Generic Name: Panobinostat Trade Name: Farydak® For which conditions is this drug approved? Farydak® is approved for use, in combination with Velcade® (bortezomib) and dexamethasone, in people with multiple myeloma after they’ve had at least two other types of treatment. What is the mechanism of action? Farydak is an agent known as a […]

View full entry

Tags: Biological Therapy, Drug Dictionary, F, farydak, Multiple Myeloma, panobinostat


February 25th, 2015

Farydak® Approval Provides Another Treatment Option for Patients With Multiple Myeloma

By

Novartis announced today that the US Food and Drug Administration (FDA) has approved Farydak® (panobinostat) in combination with Velcade® and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior regimens, including Velcade® and an immunomodulatory (IMiD) agent. The FDA approval was partially based on the results of the […]

View full entry

Tags: bortezomib, farydak, Multiple Myeloma, News, panobinostat, Recurrent Multiple Myeloma, velcade